Putnam BioRevolution ETF Rating $27.19 +0.05 (+0.18%) As of 04/25/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsRatingsBuy This Stock Putnam BioRevolution ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SYNB Aggregate RatingModerate Buy 2.81Holdings in SYNB have an aggregate rating of Moderate Buy based on 581 analyst ratings issued in the past year covering 33 companies (91.6% of the portfolio).SYNB Aggregate Price Target$27.19High Prediction$27.19Average Prediction$27.19Low Prediction$27.19Holdings in SYNB have an aggregate price target of $27.19 and a range of $27.19 to $27.19 covering 33 companies (91.6% of the portfolio).SYNB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy26 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Putnam BioRevolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 33 SYNB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.48%TMOThermo Fisher Scientific$424.02-0.6%4.9349 of 5 stars2.81$616.95 45.5%21Earnings ReportAnalyst ForecastAnalyst RevisionPositive News5.74%ABBVAbbVie$185.96+3.1%4.8854 of 5 stars2.85$211.19 13.6%26Earnings ReportAnalyst ForecastOptions VolumeAnalyst RevisionNews CoverageGap Up5.29%CTVACorteva$61.50-0.3%4.679 of 5 stars2.72$68.13 10.8%18Upcoming EarningsPositive News5.24%BIOBio-Rad Laboratories$242.22-3.0%4.6659 of 5 stars2.60$380.20 57.0%5Upcoming EarningsNews CoveragePositive News4.84%NVZMYNovozymes A/S$63.91+1.2%1.4587 of 5 stars3.003Upcoming EarningsNews Coverage4.45%LLYEli Lilly and Company$884.94+2.9%4.8241 of 5 stars2.89$1,017.00 14.9%19Upcoming EarningsAnalyst ForecastAnalyst RevisionPositive News4.35%AZNAstraZeneca$69.57+0.0%3.7263 of 5 stars3.10$88.00 26.5%10Upcoming EarningsAnalyst RevisionNews CoveragePositive News4.15%ASNDAscendis Pharma A/S$164.15+2.3%2.3276 of 5 stars2.93$204.67 24.7%15Upcoming EarningsNews CoveragePositive News4.10%NVDANVIDIA$111.01+4.3%4.9254 of 5 stars2.93$164.96 48.6%43Analyst Forecast3.96%GOOGLAlphabet$161.96+1.7%4.3014 of 5 stars2.88$198.63 22.6%40Earnings ReportDividend IncreaseAnalyst ForecastOptions VolumeAnalyst RevisionGap Up3.88%REGNRegeneron Pharmaceuticals$602.64+0.5%4.7921 of 5 stars2.88$945.32 56.9%26Upcoming EarningsAnalyst ForecastAnalyst Revision3.78%DDDuPont de Nemours$65.70-0.5%4.6969 of 5 stars2.79$86.93 32.3%14Upcoming EarningsAnalyst Forecast2.95%CDNSCadence Design Systems$289.63+2.8%4.4198 of 5 stars2.77$321.00 10.8%13Upcoming EarningsAnalyst UpgradePositive News2.81%AVTRAvantor$12.93-16.6%4.7613 of 5 stars2.83$24.82 91.9%12Earnings ReportNews CoveragePositive NewsGap DownHigh Trading Volume2.75%DARDarling Ingredients$31.98+5.0%3.9261 of 5 stars2.89$50.33 57.4%9Earnings ReportAnalyst ForecastNews CoveragePositive News2.53%NGVTIngevity$32.86+0.0%3.0664 of 5 stars2.60$52.20 58.9%5Upcoming EarningsGap Up2.38%ICLRICON Public$144.96-0.7%3.9856 of 5 stars2.67$232.67 60.5%15Upcoming Earnings2.33%DHRDanaher$197.37+0.4%4.9593 of 5 stars2.80$264.40 34.0%20Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.95%ONONON$45.01+0.6%3.9289 of 5 stars2.96$60.00 33.3%23News CoveragePositive News1.68%ARGXargenx$614.76+2.4%3.4881 of 5 stars2.91$699.28 13.7%23News CoveragePositive News1.68%BMRNBioMarin Pharmaceutical$63.30+0.9%4.8884 of 5 stars2.70$93.14 47.1%23Upcoming EarningsAnalyst UpgradePositive News1.58%PPGPPG Industries$102.65-1.4%4.8794 of 5 stars2.43$130.67 27.3%14Upcoming EarningsAnalyst RevisionPositive News1.55%VRTXVertex Pharmaceuticals$493.84+0.3%4.0316 of 5 stars2.64$514.91 4.3%25Analyst ForecastAnalyst RevisionPositive News1.33%TECHBio-Techne$50.24-1.1%4.8285 of 5 stars2.38$81.14 61.5%8Upcoming Earnings1.12%ZTSZoetis$153.58+0.8%4.6066 of 5 stars3.08$214.40 39.6%12Analyst RevisionPositive News1.11%BIIBBiogen$118.84-0.6%4.7177 of 5 stars2.42$211.37 77.9%31Upcoming EarningsAnalyst ForecastAnalyst RevisionNews Coverage1.07%ALNYAlnylam Pharmaceuticals$251.56+3.7%4.6055 of 5 stars2.77$315.58 25.5%26Upcoming EarningsAnalyst UpgradePositive News0.95%EXASExact Sciences$45.46-0.3%4.2775 of 5 stars2.95$69.25 52.3%22Upcoming EarningsAnalyst RevisionNews CoveragePositive News0.95%TWSTTwist Bioscience$40.11-0.1%3.6397 of 5 stars2.70$52.80 31.6%10News CoveragePositive News0.93%BGBunge Global$80.99+0.2%4.1063 of 5 stars2.60$85.60 5.7%5Positive News0.64%LEGNLegend Biotech$34.28+0.1%2.2416 of 5 stars2.92$78.82 129.9%12Analyst Forecast0.62%RCKTRocket Pharmaceuticals$7.23-2.7%4.658 of 5 stars2.92$43.00 494.7%12News CoveragePositive News0.40%CRSPCRISPR Therapeutics$38.27-2.1%2.7395 of 5 stars2.48$73.11 91.0%21 This page (NYSEARCA:SYNB) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored2025 could be "worse than the dot-com bust", says man who predicted 2008 banking crisisWhat's coming next to the U.S. market could be worse than anything we've ever seen before – worse than the dot...Stansberry Research | SponsoredDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Putnam BioRevolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Putnam BioRevolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SYNB Stock Free SYNB Stock Alerts